Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model
RS Schwartz,
KC Huber,
JG Murphy,
WD Edwards,
AR Camrud,
RE Vlietstra,
and
DR Holmes
Division of Cardiovascular Diseases, Mayo Graduate School of Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905.
Restenosis is a reparative response to arterial injury occurring with percutaneous coronary revascularization. However, the quantitative characteristics of the relation between vessel injury and the magnitude of restenotic response remain unknown. This study was thus performed to determine the relation between severity of vessel wall injury and the thickness of resulting neointimal proliferation in a porcine model of coronary restenosis. Twenty-six porcine coronary artery segments in 24 pigs were subjected to deep arterial injury with use of overexpanded, percutaneously delivered tantalum wire coils. The vessels were studied microscopically 4 weeks after coil implantation to measure the relation between the extent of injury and the resulting neointimal thickness. For each wire site, a histopathologic score proportional to injury depth and the neointimal thicknesses at that site were determined. Mean injury scores were compared with both mean neointimal thickness and planimetry-derived area percent lumen stenosis. The severity of vessel injury strongly correlated with neointimal thickness and percent diameter stenosis (p less than 0.001). Neointimal proliferation resulting from a given wire was related to injury severity in adjacent wires, suggesting an interaction among effects at injured sites. If the results in this model apply to human coronary arteries, restenosis may depend on the degree of vessel injury sustained during angioplasty.
This article has been cited by other articles:

|
 |

|
 |
 
N Gonzalo, P W Serruys, T Okamura, Z J Shen, Y Onuma, H M Garcia-Garcia, G Sarno, C Schultz, R J van Geuns, J Ligthart, et al.
Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach
Heart,
December 1, 2009;
95(23):
1913 - 1919.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Sera, M. Awata, M. Uematsu, J.-i. Kotani, S. Nanto, and S. Nagata
Optimal Stent-Sizing With Intravascular Ultrasound Contributes to Complete Neointimal Coverage After Sirolimus-Eluting Stent Implantation Assessed by Angioscopy
J. Am. Coll. Cardiol. Intv.,
October 1, 2009;
2(10):
989 - 994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Mintz and S.-Y. Choi
Optimal Stent Expansion and Complete Neointimal Coverage: Does This Association Make Sense?
J. Am. Coll. Cardiol. Intv.,
October 1, 2009;
2(10):
995 - 996.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chamberlain, M. Wheatcroft, N. Arnold, H. Lupton, D. C. Crossman, J. Gunn, and S. Francis
A novel mouse model of in situ stenting
Cardiovasc Res,
August 12, 2009;
(2009)
cvp262v2.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.F. Kallmes, Y.H. Ding, D. Dai, R. Kadirvel, D.A. Lewis, and H.J. Cloft
A Second-Generation, Endoluminal, Flow-Disrupting Device for Treatment of Saccular Aneurysms
AJNR Am. J. Neuroradiol.,
June 1, 2009;
30(6):
1153 - 1158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Suzuki, A. C. Yeung, and F. Ikeno
The Pre-Clinical Animal Model in the Translational Research of Interventional Cardiology
J. Am. Coll. Cardiol. Intv.,
May 1, 2009;
2(5):
373 - 383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. van der Giessen, O. Sorop, P. W. Serruys, I. Peters-Krabbendam, and H. M.M. van Beusekom
Lowering the Dose of Sirolimus, Released From a Nonpolymeric Hydroxyapatite Coated Coronary Stent, Reduces Signs of Delayed Healing
J. Am. Coll. Cardiol. Intv.,
April 1, 2009;
2(4):
284 - 290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Maeng, L O Jensen, E Falk, H R Andersen, and L Thuesen
Negative vascular remodelling after implantation of bioabsorbable magnesium alloy stents in porcine coronary arteries: a randomised comparison with bare-metal and sirolimus-eluting stents
Heart,
February 1, 2009;
95(3):
241 - 246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Schwartz, E. Edelman, R. Virmani, A. Carter, J. F. Granada, G. L. Kaluza, N. A.F. Chronos, K. A. Robinson, R. Waksman, J. Weinberger, et al.
Drug-Eluting Stents in Preclinical Studies: Updated Consensus Recommendations for Preclinical Evaluation
Circ Cardiovasc Interv,
October 1, 2008;
1(2):
143 - 153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C Mcmahon, H. Zreiqat, and H. C Lowe
Carotid artery stenting in the Zucker rat: a novel, potentially 'diabetes-specific' model of in-stent restenosis
Diabetes and Vascular Disease Research,
June 1, 2008;
5(2):
145 - 146.
[PDF]
|
 |
|

|
 |

|
 |
 
E. Romagnoli, G. M. Sangiorgi, J. Cosgrave, E. Guillet, and A. Colombo
Drug-eluting stenting the case for post-dilation.
J. Am. Coll. Cardiol. Intv.,
February 1, 2008;
1(1):
22 - 31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Jabara, N. Chronos, D. Conway, W. Molema, and K. Robinson
Evaluation of a novel slow-release Paclitaxel-eluting stent with a bioabsorbable polymeric surface coating.
J. Am. Coll. Cardiol. Intv.,
February 1, 2008;
1(1):
81 - 87.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. F. Kallmes, Y. H. Ding, D. Dai, R. Kadirvel, D. A. Lewis, and H. J. Cloft
A New Endoluminal, Flow-Disrupting Device for Treatment of Saccular Aneurysms
Stroke,
August 1, 2007;
38(8):
2346 - 2352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Salahas, A. Vrahatis, I. Karabinos, I. Antonellis, G. Ifantis, I. Gavaliatsis, P. Anthopoulos, and A. Tavernarakis
Success, Safety, and Efficacy of Implantation of Diamond-Like Carbon-Coated Stents
Angiology,
April 1, 2007;
58(2):
203 - 210.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. A. Ali, N. J. Alp, H. Lupton, N. Arnold, T. Bannister, Y. Hu, S. Mussa, M. Wheatcroft, D. R. Greaves, J. Gunn, et al.
Increased In-Stent Stenosis in ApoE Knockout Mice: Insights from a Novel Mouse Model of Balloon Angioplasty and Stenting
Arterioscler Thromb Vasc Biol,
April 1, 2007;
27(4):
833 - 840.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Tang, X. Chen, S. Tang, T. LaLonde, and J. M Gardin
Granulation encapsulated stent: a new therapeutic approach for vascular implantation
Heart,
February 1, 2007;
93(2):
238 - 243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Joner, A. Farb, Q. Cheng, A. V. Finn, E. Acampado, A. P. Burke, K. Skorija, W. Creighton, F. D. Kolodgie, H. K. Gold, et al.
Pioglitazone Inhibits In-Stent Restenosis in Atherosclerotic Rabbits by Targeting Transforming Growth Factor-{beta} and MCP-1
Arterioscler Thromb Vasc Biol,
January 1, 2007;
27(1):
182 - 189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ohtani, K. Egashira, K. Nakano, G. Zhao, K. Funakoshi, Y. Ihara, S. Kimura, R. Tominaga, R. Morishita, and K. Sunagawa
Stent-Based Local Delivery of Nuclear Factor-{kappa}B Decoy Attenuates In-Stent Restenosis in Hypercholesterolemic Rabbits
Circulation,
December 19, 2006;
114(25):
2773 - 2779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Yang, J. Ge, H. Liu, K. Zhao, X. Liu, X. Qu, W. Li, Y. Huang, A. Sun, and Y. Zou
Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model
Cardiovasc Res,
December 1, 2006;
72(3):
483 - 493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ishii, F. Vinuela, Y. Murayama, I. Yuki, Y.L. Nien, D.T. Yeh, and H.V. Vinters
Swine model of carotid artery atherosclerosis: experimental induction by surgical partial ligation and dietary hypercholesterolemia.
AJNR Am. J. Neuroradiol.,
October 1, 2006;
27(9):
1893 - 1899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Speck, B. Scheller, C. Abramjuk, C. Breitwieser, J. Dobberstein, M. Boehm, and B. Hamm
Neointima Inhibition: Comparison of Effectiveness of Non-Stent-based Local Drug Delivery and a Drug-eluting Stent in Porcine Coronary Arteries.
Radiology,
August 1, 2006;
240(2):
411 - 418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K D Krueger, A K Mitra, M G DelCore, W J Hunter III, and D K Agrawal
A comparison of stent-induced stenosis in coronary and peripheral arteries
J. Clin. Pathol.,
June 1, 2006;
59(6):
575 - 579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Garcia-Touchard, S. E. Burke, J. L. Toner, K. Cromack, and R. S. Schwartz
Zotarolimus-eluting stents reduce experimental coronary artery neointimal hyperplasia after 4 weeks
Eur. Heart J.,
April 2, 2006;
27(8):
988 - 993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. Cheema, T. Hong, N. Nili, A. Segev, J. G. Moffat, K. E. Lipson, A. R. Howlett, D. W. Holdsworth, M. J. Cole, B. Qiang, et al.
Adventitial Microvessel Formation After Coronary Stenting and the Effects of SU11218, a Tyrosine Kinase Inhibitor
J. Am. Coll. Cardiol.,
March 7, 2006;
47(5):
1067 - 1075.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Salu, J. M. Bosmans, Y. Huang, M. Hendriks, M. Verhoeven, A. Levels, S. Cooper, I. K. De Scheerder, C. J. Vrints, and H. Bult
Effects of cytochalasin D-eluting stents on intimal hyperplasia in a porcine coronary artery model
Cardiovasc Res,
February 1, 2006;
69(2):
536 - 544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Touchard and R. S. Schwartz
Preclinical Restenosis Models: Challenges and Successes
Toxicol Pathol,
January 1, 2006;
34(1):
11 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C J Dean, A C Morton, N D Arnold, D R Hose, D C Crossman, and J Gunn
Relative importance of the components of stent geometry to stretch induced in-stent neointima formation
Heart,
December 1, 2005;
91(12):
1603 - 1604.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Fujiu, I. Manabe, A. Ishihara, Y. Oishi, H. Iwata, G. Nishimura, T. Shindo, K. Maemura, H. Kagechika, K. Shudo, et al.
Synthetic Retinoid Am80 Suppresses Smooth Muscle Phenotypic Modulation and In-Stent Neointima Formation by Inhibiting KLF5
Circ. Res.,
November 25, 2005;
97(11):
1132 - 1141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Kwak, H. J. Shim, S.-M. Han, and E. S. Park
Chitin-based Embolic Materials in the Renal Artery of Rabbits: Pathologic Evaluation of an Absorbable Particulate Agent
Radiology,
July 1, 2005;
236(1):
151 - 158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Costa and D. I. Simon
Molecular Basis of Restenosis and Drug-Eluting Stents
Circulation,
May 3, 2005;
111(17):
2257 - 2273.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Wessely, J. Hausleiter, C. Michaelis, B. Jaschke, M. Vogeser, S. Milz, B. Behnisch, T. Schratzenstaller, M. Renke-Gluszko, M. Stover, et al.
Inhibition of Neointima Formation by a Novel Drug-Eluting Stent System That Allows for Dose-Adjustable, Multiple, and On-Site Stent Coating
Arterioscler Thromb Vasc Biol,
April 1, 2005;
25(4):
748 - 753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H C Lowe, B James, and L M Khachigian
A novel model of in-stent restenosis: rat aortic stenting
Heart,
March 1, 2005;
91(3):
393 - 395.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Lee, D. H. Kim, B.-H. Lee, H. J. Kim, C. H. Choi, K. P. Park, D. S. Jung, S. Kim, and T. Y. Moon
Preliminary Results of Endovascular Stent-Assisted Angioplasty for Symptomatic Middle Cerebral Artery Stenosis
AJNR Am. J. Neuroradiol.,
January 1, 2005;
26(1):
166 - 174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Langeveld, W. H. van Gilst, R. A. Tio, F. Zijlstra, and A. J.M. Roks
Angiotensin-(1-7) Attenuates Neointimal Formation After Stent Implantation in the Rat
Hypertension,
January 1, 2005;
45(1):
138 - 141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Schwartz, N. A. Chronos, and R. Virmani
Preclinical restenosis models and drug-eluting stents: Still important, still much to learn
J. Am. Coll. Cardiol.,
October 6, 2004;
44(7):
1373 - 1385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Scheller, U. Speck, C. Abramjuk, U. Bernhardt, M. Bohm, and G. Nickenig
Paclitaxel Balloon Coating, a Novel Method for Prevention and Therapy of Restenosis
Circulation,
August 17, 2004;
110(7):
810 - 814.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Vogt, A. Stein, G. Rettemeier, N. Krott, R. Hoffmann, J. v. Dahl, A.-K. Bosserhoff, W. Michaeli, P. Hanrath, C. Weber, et al.
Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent
Eur. Heart J.,
August 1, 2004;
25(15):
1330 - 1340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Walter, M. Cejna, L. Diaz-Sandoval, S. Willis, L. Kirkwood, P. W. Stratford, A. B. Tietz, R. Kirchmair, M. Silver, C. Curry, et al.
Local Gene Transfer of phVEGF-2 Plasmid by Gene-Eluting Stents: An Alternative Strategy for Inhibition of Restenosis
Circulation,
July 6, 2004;
110(1):
36 - 45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Ma and E. R. O'Brien
Antagonism of the {alpha}4 integrin subunit attenuates the acute inflammatory response to stent implantation yet is insufficient to prevent late intimal formation
J. Leukoc. Biol.,
June 1, 2004;
75(6):
1016 - 1021.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. H Chong and J. W. Cheng
Early Experiences and Clinical Implications of Drug-Eluting Stents: Part 1
Ann. Pharmacother.,
April 1, 2004;
38(4):
661 - 669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A C Morton, N D Arnold, D C Crossman, and J Gunn
Response of very small (2 mm) porcine coronary arteries to balloon angioplasty and stent implantation
Heart,
March 1, 2004;
90(3):
324 - 327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Bax and P. V. Oemrawsingh
Can Molecular Imaging Predict In-Stent Restenosis?
J. Nucl. Med.,
February 1, 2004;
45(2):
300 - 301.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A C Morton and J Gunn
Methotrexate eluting stents: to modify or cure?
Heart,
February 1, 2004;
90(2):
121 - 122.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y Huang, K Salu, X Liu, S Li, L Wang, E Verbeken, J Bosmans, and I De Scheerder
Methotrexate loaded SAE coated coronary stents reduce neointimal hyperplasia in a porcine coronary model
Heart,
February 1, 2004;
90(2):
195 - 199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-H. Chen, L.-Y. Chau, M.-W. Lin, L.-C. Chen, M.-H. Yo, J.-W. Chen, and S.-J. Lin
Heme oxygenase-1 gene promotor microsatellite polymorphism is associated with angiographic restenosis after coronary stenting
Eur. Heart J.,
January 1, 2004;
25(1):
39 - 47.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Matsumoto, T. Uwatoku, K. Oi, K. Abe, T. Hattori, K. Morishige, Y. Eto, Y. Fukumoto, K.-i. Nakamura, Y. Shibata, et al.
Long-Term Inhibition of Rho-Kinase Suppresses Neointimal Formation After Stent Implantation in Porcine Coronary Arteries: Involvement of Multiple Mechanisms
Arterioscler Thromb Vasc Biol,
January 1, 2004;
24(1):
181 - 186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Scheller, U. Speck, A. Schmitt, M. Bohm, and G. Nickenig
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation
J. Am. Coll. Cardiol.,
October 15, 2003;
42(8):
1415 - 1420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Pearce and J. F. McKinsey
Current Status of Intravascular Stents as Delivery Devices to Prevent Restenosis
Vascular and Endovascular Surgery,
July 1, 2003;
37(4):
231 - 237.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Carlier, L. C.A. van Damme, C. P. Blommerde, J. J. Wentzel, G. van Langehove, S. Verheye, M. M. Kockx, M. W.M. Knaapen, C. Cheng, F. Gijsen, et al.
Augmentation of Wall Shear Stress Inhibits Neointimal Hyperplasia After Stent Implantation: Inhibition Through Reduction of Inflammation?
Circulation,
June 3, 2003;
107(21):
2741 - 2746.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B Heublein, R Rohde, V Kaese, M Niemeyer, W Hartung, and A Haverich
Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology?
Heart,
June 1, 2003;
89(6):
651 - 656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kaul, V. Rukshin, R. Santos, B. Azarbal, C. L. Bisgaier, J. Johansson, V. T. Tsang, K.-Y. Chyu, B. Cercek, J. Mirocha, et al.
Intramural Delivery of Recombinant Apolipoprotein A-IMilano/Phospholipid Complex (ETC-216) Inhibits In-Stent Stenosis in Porcine Coronary Arteries
Circulation,
May 27, 2003;
107(20):
2551 - 2554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Lau, S. B. Leichtweis, P. Hume, R. Mashima, J. Y. Hou, X. Chaufour, B. Wilkinson, N. H. Hunt, D. S. Celermajer, and R. Stocker
Probucol Promotes Functional Reendothelialization in Balloon-Injured Rabbit Aortas
Circulation,
April 22, 2003;
107(15):
2031 - 2036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Karnik, B. S. Brooke, A. Bayes-Genis, L. Sorensen, J. D. Wythe, R. S. Schwartz, M. T. Keating, and D. Y. Li
A critical role for elastin signaling in vascular morphogenesis and disease
Development,
March 2, 2003;
130(2):
411 - 423.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B E Bouma, G J Tearney, H Yabushita, M Shishkov, C R Kauffman, D DeJoseph Gauthier, B D MacNeill, S L Houser, H T Aretz, E F Halpern, et al.
Evaluation of intracoronary stenting by intravascular optical coherence tomography
Heart,
March 1, 2003;
89(3):
317 - 320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Finkelstein, D. McClean, S. Kar, K. Takizawa, K. Varghese, N. Baek, K. Park, M. C. Fishbein, R. Makkar, F. Litvack, et al.
Local Drug Delivery via a Coronary Stent With Programmable Release Pharmacokinetics
Circulation,
February 11, 2003;
107(5):
777 - 784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R Virmani, F D Kolodgie, A Farb, and A Lafont
Drug eluting stents: are human and animal studies comparable?
Heart,
February 1, 2003;
89(2):
133 - 138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. P. Casserly, H. D. Aronow, P. Schoenhagen, H. Tsutsui, J. Popovich, M. Goormastic, J. J. Popma, S. E. Nissen, and E. M. Tuzcu
Relationship between residual atheroma burden and neointimal growth in patients undergoing stenting: Analysis of the atherectomy before MULTI-LINK improves lumen gain and clinical outcomes trial intravascular ultrasound substudy
J. Am. Coll. Cardiol.,
November 6, 2002;
40(9):
1573 - 1578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Cheneau, R. Waksman, H. Yazdi, R. Chan, J. Fourdnadjiev, C. Berzingi, V. Shah, A. E. Ajani, L. Leborgne, and F. O. Tio
How to Fix the Edge Effect of Catheter-Based Radiation Therapy in Stented Arteries
Circulation,
October 22, 2002;
106(17):
2271 - 2277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Regar, P.W. Serruys, C. Bode, C. Holubarsch, J.L. Guermonprez, W. Wijns, A. Bartorelli, C. Constantini, M. Degertekin, K. Tanabe, et al.
Angiographic Findings of the Multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): Sirolimus-Eluting Stents Inhibit Restenosis Irrespective of the Vessel Size
Circulation,
October 8, 2002;
106(15):
1949 - 1956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Gunn, N Arnold, K H Chan, L Shepherd, D C Cumberland, and D C Crossman
Coronary artery stretch versus deep injury in the development of in-stent neointima
Heart,
October 1, 2002;
88(4):
401 - 405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Schwartz, E. R. Edelman, A. Carter, N. Chronos, C. Rogers, K. A. Robinson, R. Waksman, J. Weinberger, R. L. Wilensky, D. N. Jensen, et al.
Drug-Eluting Stents in Preclinical Studies: Recommended Evaluation From a Consensus Group
Circulation,
October 1, 2002;
106(14):
1867 - 1873.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Briguori, C. Sarais, P. Pagnotta, F. Liistro, M. Montorfano, A. Chieffo, F. Sgura, N. Corvaja, R. Albiero, G. Stankovic, et al.
In-stent restenosis in small coronary arteries: Impact of strut thickness
J. Am. Coll. Cardiol.,
August 7, 2002;
40(3):
403 - 409.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Theilmeier, R. Quarck, P. Verhamme, M.-L. Bochaton-Piallat, M. Lox, H. Bernar, S. Janssens, M. Kockx, G. Gabbiani, D. Collen, et al.
Hypercholesterolemia impairs vascular remodelling after porcine coronary angioplasty
Cardiovasc Res,
August 1, 2002;
55(2):
385 - 395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Palmerini, M. A. Nedelman, L. E. Scudder, M. T. Nakada, R. E. Jordan, S. Smyth, R. E. Gordon, J. T. Fallon, and B. S. Coller
Effects of abciximab on the acute pathology of blood vessels after arterial stenting in nonhuman primates
J. Am. Coll. Cardiol.,
July 17, 2002;
40(2):
360 - 366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Sousa, M. A. Costa, and A. G.M.R. Sousa
What Is "The Matter" With Restenosis in 2002?
Circulation,
June 25, 2002;
105(25):
2932 - 2933.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Farb, D. K. Weber, F. D. Kolodgie, A. P. Burke, and R. Virmani
Morphological Predictors of Restenosis After Coronary Stenting in Humans
Circulation,
June 25, 2002;
105(25):
2974 - 2980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Sinnaeve, J.-D. Chiche, H. Gillijns, N. Van Pelt, D. Wirthlin, F. Van de Werf, D. Collen, K. D. Bloch, and S. Janssens
Overexpression of a Constitutively Active Protein Kinase G Mutant Reduces Neointima Formation and In-Stent Restenosis
Circulation,
June 18, 2002;
105(24):
2911 - 2916.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Li, W. J. Cantor, N. Nili, R. Robinson, L. Fenkell, Y. L. e Tran, H. A. Whittingham, W. Tsui, A. N. Cheema, J. D. Sparkes, et al.
Arterial repair after stenting and the effects of gm6001, a matrix metalloproteinase inhibitor
J. Am. Coll. Cardiol.,
June 5, 2002;
39(11):
1852 - 1858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Ward, A. Agrotis, P. Kanellakis, J. Hall, G. Jennings, and A. Bobik
Tranilast Prevents Activation of Transforming Growth Factor-{beta} System, Leukocyte Accumulation, and Neointimal Growth in Porcine Coronary Arteries After Stenting
Arterioscler Thromb Vasc Biol,
June 1, 2002;
22(6):
940 - 948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yoshitomi, S. Kojima, M. Yano, Y. Matsumoto, T. Sugi, M. Saotome, K.-e Tanaka, M. Endo, and M. Kuramochi
Peristent Tissue Proliferation of Multilink Stents Is Dependent on Preprocedural Plaque Area: A Serial Intravascular Ultrasound Analysis
Angiology,
May 1, 2002;
53(3):
303 - 311.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Horvath, F. G.P. Welt, M. Nedelman, P. Rao, and C. Rogers
Targeting CCR2 or CD18 Inhibits Experimental In-Stent Restenosis in Primates: Inhibitory Potential Depends on Type of Injury and Leukocytes Targeted
Circ. Res.,
March 8, 2002;
90(4):
488 - 494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Buchwald, A. H. Wagner, C. Webel, and M. Hecker
Decoy oligodeoxynucleotide againstactivator protein-1 reducesneointimal proliferation after coronaryangioplasty in hypercholesterolemic minipigs
J. Am. Coll. Cardiol.,
February 20, 2002;
39(4):
732 - 738.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. C. Lowe, S. N. Oesterle, and L. M. Khachigian
Coronary in-stent restenosis: Current status and future strategies
J. Am. Coll. Cardiol.,
January 16, 2002;
39(2):
183 - 193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Arakawa, K. Hagisawa, H. Kusano, S. Yoneyama, A. Kurita, T. Arai, M. Kikuchi, I. Sakata, S.-i. Umenura, and F. Ohsuzu
Sonodynamic Therapy Decreased Neointimal Hyperplasia After Stenting in the Rabbit Iliac Artery
Circulation,
January 15, 2002;
105(2):
149 - 151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Windecker and B. Meier
All stents are not alike or is the difference in the eye of the observer only?
Eur. Heart J.,
November 1, 2001;
22(21):
1973 - 1977.
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hoffmann, C. Jansen, A. Konig, P.K. Haager, G. Kerckhoff, J. Vom Dahl, V. Klauss, P. Hanrath, and H. Mudra
Stent design related neointimal tissue proliferation in human coronary arteries; an intravascular ultrasound study
Eur. Heart J.,
November 1, 2001;
22(21):
2007 - 2014.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hoffmann, P. Haager, G.S. Mintz, G. Kerckhoff, R. Schwarz, A. Franke, J. Vom Dahl, and P. Hanrath
The impact of high pressure vs low pressure stent implantation on intimal hyperplasia and follow-up lumen dimensions; results of a randomized trial
Eur. Heart J.,
November 1, 2001;
22(21):
2015 - 2024.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Lambert, N. Malik, L. Shepherd, J. Gunn, S. E. Francis, A. King, D. C. Crossman, D. C. Cumberland, and C. M. Holt
Localization of c-Myb and Induction of Apoptosis by Antisense Oligonucleotide c-myb After Angioplasty of Porcine Coronary Arteries
Arterioscler Thromb Vasc Biol,
November 1, 2001;
21(11):
1727 - 1732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Rosenthal, T. J. Bohlmeyer, E. Monnet, C. MacPhail, A. D. Robertson, M. A. Horwitz, J. E.B. Burchenal, and L. D. Horwitz
An Iron-Binding Exochelin Prevents Restenosis Due to Coronary Artery Balloon Injury in a Porcine Model
Circulation,
October 30, 2001;
104(18):
2222 - 2227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. De Leon, J. D. Ollerenshaw, K. K. Griendling, and J. N. Wilcox
Adventitial Cells Do Not Contribute to Neointimal Mass After Balloon Angioplasty of the Rat Common Carotid Artery
Circulation,
October 2, 2001;
104(14):
1591 - 1593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Work, A. R. McPhaden, N. J. Pyne, S. Pyne, R. M. Wadsworth, and C. L. Wainwright
Short-Term Local Delivery of an Inhibitor of Ras Farnesyltransferase Prevents Neointima Formation In Vivo After Porcine Coronary Balloon Angioplasty
Circulation,
September 25, 2001;
104(13):
1538 - 1543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Mudra, C. di Mario, P. de Jaegere, H. R. Figulla, C. Macaya, R. Zahn, B. Wennerblom, W. Rutsch, V. Voudris, E. Regar, et al.
Randomized Comparison of Coronary Stent Implantation Under Ultrasound or Angiographic Guidance to Reduce Stent Restenosis (OPTICUS Study)
Circulation,
September 18, 2001;
104(12):
1343 - 1349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Windecker, I. Mayer, G. De Pasquale, W. Maier, O. Dirsch, P. De Groot, Y.-P. Wu, G. Noll, B. Leskosek, B. Meier, et al.
Stent Coating With Titanium-Nitride-Oxide for Reduction of Neointimal Hyperplasia
Circulation,
August 21, 2001;
104(8):
928 - 933.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Tepe, L. M. Dinkelborg, U. Brehme, P. Muschick, B. Noll, T. Dietrich, A. Greschniok, A. Baumbach, C. D. Claussen, and S. H. Duda
Prophylaxis of Restenosis With 186Re-Labeled Stents in a Rabbit Model
Circulation,
August 6, 2001;
104(4):
480 - 485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Sianos, I. P. Kay, M. A. Costa, E. Regar, K. Kozuma, P. J. de Feyter, E. Boersma, C. Disco, and P. W. Serruys
Geographical miss during catheter-based intracoronary beta-radiation: incidence and implications in the BRIE study
J. Am. Coll. Cardiol.,
August 1, 2001;
38(2):
415 - 420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bayes-Genis, A. R. Camrud, M. Jorgenson, J. Donovan, K. L. Shogren, D. R. Holmes Jr, and R. S. Schwartz
Pressure rinsing of coronary stents immediately before implantation reduces inflammation and neointimal hyperplasia
J. Am. Coll. Cardiol.,
August 1, 2001;
38(2):
562 - 568.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Albertal, G Van Langenhove, E Regar, I P Kay, D Foley, G Sianos, K Kozuma, T Beijsterveldt, S G Carlier, J A Belardi, et al.
Uncomplicated moderate coronary artery dissections after balloon angioplasty: good outcome without stenting
Heart,
August 1, 2001;
86(2):
193 - 198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Farb, P. F. Heller, S. Shroff, L. Cheng, F. D. Kolodgie, A. J. Carter, D. S. Scott, J. Froehlich, and R. Virmani
Pathological Analysis of Local Delivery of Paclitaxel Via a Polymer-Coated Stent
Circulation,
July 24, 2001;
104(4):
473 - 479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Heldman, L. Cheng, G. M. Jenkins, P. F. Heller, D.-W. Kim, M. Ware Jr, C. Nater, R. H. Hruban, B. Rezai, B. S. Abella, et al.
Paclitaxel Stent Coating Inhibits Neointimal Hyperplasia at 4 Weeks in a Porcine Model of Coronary Restenosis
Circulation,
May 8, 2001;
103(18):
2289 - 2295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. R. Huckle, M. D. Drag, W. R. Acker, M. Powers, R. C. McFall, D. J. Holder, T. F. Walsh, R. S. Schwartz, W. J. Greenlee, and R. G. Johnson Jr
Effects of L-749,329, an ETA/ETB Endothelin Receptor Antagonist, in a Porcine Coronary Artery Injury Model of Vascular Restenosis
Circulation,
April 10, 2001;
103(14):
1899 - 1905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.A Costa, L.E.A de Wit, V de Valk, P Serrano, A.J Wardeh, P.W Serruys, and W Sluiter
Indirect evidence for a role of a subpopulation of activated neutrophils in the remodelling process after percutaneous coronary intervention
Eur. Heart J.,
April 1, 2001;
22(7):
580 - 586.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kobayashi, Y. Honda, L. G. Christie, P. S. Teirstein, S. R. Bailey, C. L. Brown III, R. V. Matthews, A. C. De Franco, R. S. Schwartz, S. Goldberg, et al.
Long-term vessel response to a self-expanding coronary stent: a serial volumetric intravascular ultrasound analysis from the ASSURE trial
J. Am. Coll. Cardiol.,
April 1, 2001;
37(5):
1329 - 1334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bayes-Genis, R. S. Schwartz, D. A. Lewis, M. T. Overgaard, M. Christiansen, C. Oxvig, K. Ashai, D. R. Holmes Jr, and C. A. Conover
Insulin-Like Growth Factor Binding Protein-4 Protease Produced by Smooth Muscle Cells Increases in the Coronary Artery After Angioplasty
Arterioscler Thromb Vasc Biol,
March 1, 2001;
21(3):
335 - 341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Napoli, G. Cirino, P. Del Soldato, R. Sorrentino, V. Sica, M. Condorelli, A. Pinto, and L. J. Ignarro
Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice
PNAS,
February 27, 2001;
98(5):
2860 - 2864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fenton, S. Barker, D. J. Kurz, and J. D. Erusalimsky
Cellular Senescence After Single and Repeated Balloon Catheter Denudations of Rabbit Carotid Arteries
Arterioscler Thromb Vasc Biol,
February 1, 2001;
21(2):
220 - 226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Edelman, P. Seifert, A. Groothuis, A. Morss, D. Bornstein, and C. Rogers
Gold-Coated NIR Stents in Porcine Coronary Arteries
Circulation,
January 23, 2001;
103(3):
429 - 434.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Hehrlein, A Kovacs, G.K Wolf, N Yue, and R Nath
A novel balloon angioplasty catheter impregnated with beta-particle emitting radioisotopes for vascular brachytherapy to prevent restenosis. First in vivo results
Eur. Heart J.,
December 2, 2000;
21(24):
2056 - 2062.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Roque, E. D. Reis, V. Fuster, A. Padurean, J. T. Fallon, M. B. Taubman, J. H. Chesebro, and J. J. Badimon
Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty
J. Am. Coll. Cardiol.,
December 1, 2000;
36(7):
2303 - 2310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Drachman, E. R. Edelman, P. Seifert, A. R. Groothuis, D. A. Bornstein, K. R. Kamath, M. Palasis, D. Yang, S. H. Nott, and C. Rogers
Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months
J. Am. Coll. Cardiol.,
December 1, 2000;
36(7):
2325 - 2332.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|